4//SEC Filing
GOLDSTEIN JOSEPH L 4
Accession 0001883850-22-000032
CIK 0000872589other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:08 PM ET
Size
8.4 KB
Accession
0001883850-22-000032
Insider Transaction Report
Form 4
GOLDSTEIN JOSEPH L
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-30$374.12/sh+2,431$909,486→ 8,513 total - Sale
Common Stock
2022-03-30$700.00/sh−2,431$1,701,700→ 6,082 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-03-30−2,431→ 0 totalExercise: $374.12Exp: 2030-01-02→ Common Stock (2,431 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001225474
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:08 PM ET
- Size
- 8.4 KB